Tanja B. Grammer

Medicine · Health Sciences

46h-index16.0kcitations185works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Lipoproteins and Cardiovascular Health(57), Diabetes, Cardiovascular Risks, and Lipoproteins(29), Vitamin D Research Studies(17), Atherosclerosis and Cardiovascular Diseases(16), Genetic Associations and Epidemiology(14)

Publications171 total

NFAT5 and SLC4A10 loci associate with plasma osmolality
UNC Libraries·2024Open Access
The German care high registry for familial hypercholesterolemia –Sex differences, treatment strategies, and target value attainment
Atherosclerosis·2023Open Access
The German CaRe high registry for familial hypercholesterolemia – Sex differences, treatment strategies, and target value attainment
Atherosclerosis Plus·2023· 6 citedOpen Access
The German CaRe High Registry for Familial Hypercholesterolemia –Sex Differences, Treatment Strategies and Target Value Attainment
SSRN Electronic Journal·2022· 1 citedOpen Access
Anemia of Chronic Disease in Patients With Cardiovascular Disease
Frontiers in Cardiovascular Medicine·2021· 54 citedOpen Access
Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study
PLoS Medicine·2021· 120 citedOpen Access
J-shaped association between circulating apoC-III and cardiovascular mortality
European Journal of Preventive Cardiology·2021· 2 cited
Common APOC3 variants are associated with circulating ApoC-III and VLDL cholesterol but not with total apolipoprotein B and coronary artery disease
Atherosclerosis·2020· 16 cited
Risk factors for retinopathy in hemodialysis patients with type 2 diabetes mellitus
Scientific Reports·2020· 16 citedOpen Access
Author Correction: Cardiovascular risk algorithms in primary care: Results from the DETECT study
Scientific Reports·2020· 2 citedOpen Access
Comparison of lipoprotein (a) serum concentrations measured by six commercially available immunoassays
Atherosclerosis·2019· 106 citedOpen Access
Common Apoc3 Variants And Coronary Artery Disease
Atherosclerosis·2019
Cost effectiveness of lifelong therapy with PCSK9 inhibitors for lowering cardiovascular events in patients with stable coronary artery disease: Insights from the Ludwigshafen Risk and Cardiovascular Health cohort
Vascular Pharmacology·2019· 20 cited
Area-based socioeconomic status and mortality: the Ludwigshafen Risk and Cardiovascular Health study
Clinical Research in Cardiology·2019· 22 cited
Iron Metabolism, Hepcidin, and Mortality (the Ludwigshafen Risk and Cardiovascular Health Study)
Clinical Chemistry·2019· 37 citedOpen Access
Cardiovascular risk algorithms in primary care: Results from the DETECT study
Scientific Reports·2019· 26 citedOpen Access
Cardiovascular risk algorithms in primary care
2019
LDL triglycerides, hepatic lipase activity, and coronary artery disease: An epidemiologic and Mendelian randomization study
Atherosclerosis·2018· 43 cited
Gesundheitsökonomische Aspekte der Verschreibung von PCSK9-Hemmern
CardioVasc·2018
Recurrent tendosynovitis as a rare manifestation of a lipid disorder
Journal of clinical lipidology·2018· 5 cited
page 1 of 9Next →

Frequent Co-authors

Winfried März(40), Marcus E. Kleber(30), Stefan Pilz(24), Hubert Scharnagl(20), Bernhard O. Boehm(18), Günther Silbernagel(16), Andreas Tomaschitz(13), Graciela Delgado(9), Tatjana Stojaković(7), Eberhard Ritz(6), Christiane Drechsler(6), Bernd Genser(6), Bernhard R. Winkelmann(6), Andreas Meinitzer(6), Dietmar Fuchs(5), Tōnu Esko(4), Irene Mateo Leach(4), Wolfgang Köenig(4), Georg Goliasch(4), Alexander Niessner(4)